Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Christopher Westcott"'
Autor:
Rena Buckstein, Lisa Chodirker, Karen W.L. Yee, Michelle Geddes, Heather A. Leitch, Grace Christou, Versha Banerji, Brian Leber, Dina Khalaf, Eve St-Hilaire, Nicholas Finn, Thomas Nevill, Mary-Margaret Keating, John Storring, Anne Parmentier, Aksharh Thambipillai, Derek Tang, Christopher Westcott, Chris Cameron, Paul Spin
Publikováno v:
Leukemialymphoma.
Many patients with lower-risk myelodysplastic syndromes (LR MDS) require long-term red blood cell (RBC) transfusions to manage anemia. The consequences of RBC transfusions in LR MDS with ring sideroblasts (LR MDS-RS) are not well known. We estimated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ec842fa7b23e48363ede6bc64fea2b0
https://pubmed.ncbi.nlm.nih.gov/36606533
https://pubmed.ncbi.nlm.nih.gov/36606533
Autor:
Rena Buckstein, Lisa Chodirker, Lee Mozessohn, Karen W.L Yee, Michelle Geddes, Nancy Zhu, April Shamy, Heather A. Leitch, Grace Christou, Versha Banerji, Leber Brian, Dina Khalaf, Eve St-Hilaire, Nicholas Finn, Thomas Nevill, Mary-Margaret Keating, John Storring, Robert Delage, Anne Parmentier, Aksharh Thambipillai, Mohammed Siddiqui, Christopher Westcott, Chris Cameron, Alexandre Mamedov, Paul Spin, Derek Tang
Publikováno v:
Leukemialymphoma. 63(13)
Patients with lower-risk (LR) myelodysplastic syndromes (MDS) with ring sideroblasts (RS) have better prognosis than those without RS, but how they fare over time is not fully understood. This study's objective was to assess the natural history of LR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::173f6ad68c620b49783bcf18e8283323
https://pubmed.ncbi.nlm.nih.gov/36095125
https://pubmed.ncbi.nlm.nih.gov/36095125